310 related articles for article (PubMed ID: 27282415)
1. Doxorubicin-induced co-assembling nanomedicines with temperature-sensitive acidic polymer and their in-situ-forming hydrogels for intratumoral administration.
Wan J; Geng S; Zhao H; Peng X; Zhou Q; Li H; He M; Zhao Y; Yang X; Xu H
J Control Release; 2016 Aug; 235():328-336. PubMed ID: 27282415
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
[TBL] [Abstract][Full Text] [Related]
3. Encapsulation of Thermo-responsive Gel in pH-sensitive Polymersomes as Dual-Responsive Smart carriers for Controlled Release of Doxorubicin.
Oroojalian F; Babaei M; Taghdisi SM; Abnous K; Ramezani M; Alibolandi M
J Control Release; 2018 Oct; 288():45-61. PubMed ID: 30171978
[TBL] [Abstract][Full Text] [Related]
4. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance.
Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T
J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991
[TBL] [Abstract][Full Text] [Related]
5. A novel high drug loading mussel-inspired polydopamine hybrid nanoparticle as a pH-sensitive vehicle for drug delivery.
Hou J; Guo C; Shi Y; Liu E; Dong W; Yu B; Liu S; Gong J
Int J Pharm; 2017 Nov; 533(1):73-83. PubMed ID: 28943209
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin.
Ren S; Dai Y; Li C; Qiu Z; Wang X; Tian F; Zhou S; Liu Q; Xing H; Lu Y; Chen X; Li N
Eur J Pharm Sci; 2016 Sep; 92():137-45. PubMed ID: 27388491
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
Wong HL; Rauth AM; Bendayan R; Wu XY
Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
[TBL] [Abstract][Full Text] [Related]
8. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-tumor activity through combinational intratumoral injection of an in-situ injectable drug depot.
Kim DY; Kwon DY; Kwon JS; Park JH; Park SH; Oh HJ; Kim JH; Min BH; Park K; Kim MS
Biomaterials; 2016 Apr; 85():232-45. PubMed ID: 26874285
[TBL] [Abstract][Full Text] [Related]
10. Novel drug delivery system using thermoreversible gelation polymer for malignant glioma.
Arai T; Joki T; Akiyama M; Agawa M; Mori Y; Yoshioka H; Abe T
J Neurooncol; 2006 Mar; 77(1):9-15. PubMed ID: 16292493
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of doxorubicin and (131)I by thermosensitive micellar-hydrogel for enhanced in situ synergetic chemoradiotherapy.
Huang P; Zhang Y; Wang W; Zhou J; Sun Y; Liu J; Kong D; Liu J; Dong A
J Control Release; 2015 Dec; 220(Pt A):456-464. PubMed ID: 26562684
[TBL] [Abstract][Full Text] [Related]
13. cRGD-decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivo.
Gu X; Wei Y; Fan Q; Sun H; Cheng R; Zhong Z; Deng C
J Control Release; 2019 May; 301():110-118. PubMed ID: 30898610
[TBL] [Abstract][Full Text] [Related]
14. Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy.
Zou Y; Fang Y; Meng H; Meng F; Deng C; Zhang J; Zhong Z
J Control Release; 2016 Dec; 244(Pt B):326-335. PubMed ID: 27245309
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
[TBL] [Abstract][Full Text] [Related]
16. In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymer.
Kang YM; Kim GH; Kim JI; Kim DY; Lee BN; Yoon SM; Kim JH; Kim MS
Biomaterials; 2011 Jul; 32(20):4556-64. PubMed ID: 21440935
[TBL] [Abstract][Full Text] [Related]
17. Injectable in Situ Forming Hydrogels of Thermosensitive Polypyrrole Nanoplatforms for Precisely Synergistic Photothermo-Chemotherapy.
Geng S; Zhao H; Zhan G; Zhao Y; Yang X
ACS Appl Mater Interfaces; 2020 Feb; 12(7):7995-8005. PubMed ID: 32013384
[TBL] [Abstract][Full Text] [Related]
18. Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release.
Wang K; Zhang X; Zhang L; Qian L; Liu C; Zheng J; Jiang Y
Drug Deliv; 2015 May; 22(3):389-99. PubMed ID: 24670095
[TBL] [Abstract][Full Text] [Related]
19. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.
Wong HL; Bendayan R; Rauth AM; Xue HY; Babakhanian K; Wu XY
J Pharmacol Exp Ther; 2006 Jun; 317(3):1372-81. PubMed ID: 16547167
[TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacokinetics, biodistribution and the anti-tumor effect of cyclic RGD-modified doxorubicin-loaded polymers in tumor-bearing mice.
Wang C; Li Y; Chen B; Zou M
Colloids Surf B Biointerfaces; 2016 Oct; 146():31-8. PubMed ID: 27244048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]